α1-antitrypsin deficiency: More than a protease imbalance?

Chest

Volumn 125, Issue 5, 2004, Pages 1607-1609

  Wewers, Mark D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; CIGARETTE SMOKING; COST; CYTOPLASM; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; HISTORY OF MEDICINE; HUMAN; INFLAMMATION; LUNG EMPHYSEMA; LUNG STRUCTURE; PANNICULITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEGRADATION; ENZYMOLOGY; NOTE;

ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; PULMONARY EMPHYSEMA;

EID: 2442595692     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5.1607     Document Type: Editorial

References (21)

1. Laurell C-B, Eriksson S. The electrophoretic α-1-globulin pattern of serum in α-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140
2. 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316:1055-1062
3. 1-antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59
4. Suki B, Lutchen KR, Ingenito EP. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. Am J Respir Crit Care Med 2003; 168:516-521
5. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2003; 167:1387-1392
6. Silverman EK, Miletich JP, Pierce JA, et al. α-1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 140:961-966
7. Lomas DA, Silverman EK. The genetics of chronic obstructive pulmonary disease. Respir Res 2001; 2:20-26
8. 1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978; 204: 345-351
9. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease: 1. Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002; 57:736-741
10. Ralston DR, Marsh CB, Lowe MP, et al. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release: role of surface proteinase-3, α-1 antitrypsin, and Fc γ receptors. J Clin Invest 1997; 100:1416-1424
11. 1-Antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993; 43:1329-1332
12. 1-Antitrypsin deficiency: a model for conformational diseases. N Engl J Med 2002; 346:45-53
13. 1- antitrypsin by alveolar epithelial cells. FEBS Lett 1994; 346:171-174
14. 1- proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem 1997; 272:8250-8255
15. Ray P, Tang W, Wang P, et al. Regulated overexpression of interleukin 11 in the lung: use to dissociate development-dependent and -independent phenotypes. J Clin Invest 1997; 100:2501-2511
16. Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol 1999; 154:1763-1775
17. Kuhn C III, Homer RJ, Zhu Z, et al. Airway hyperresponsiveness and airway obstruction in transgenic mice: morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol 2000; 22:289-295
18. Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106: 1081-1093
19. Wang Z, Zheng T, Zhu Z, et al. Interferon γ induction of pulmonary emphysema in the adult murine lung. J Exp Med 2000; 192:1587-1600
20. Fujita M, Shannon JM, Irvin CG, et al. Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001; 280:L39-L49
21. Hardie WD, Piljan-Gentle A, Dunlavy MR, et al. Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-α. Am J Physiol Lung Cell Mol Physiol 2001; 281:L1088-L1094